Our long-term OBJECTIVES remain to apply the fundamental concepts and broad technologies of cell and molecular biology to understand hepatic epithelial cell function and dysfunction. We now focus principally on cholangiocytes, epithelial cells that line intrahepatic bile ducts, because of their biologic and clinical importance, the new hypotheses and techniques we have developed for their study, and the role we have played in advancing cholangiocyte pathobiology, an underserved area of research. We will utilize novel experimental models, methods, and probes to investigate cholangiocyte water and solute transport by testing the CENTRAL HYPOTHESIS that cholangiocyte bile production is the net result of solute-driven, bi- directional, passive movement of water molecules through water- selective channels [Aquaporins (AQPs)] constituitively expressed on or recycled among cholangiocyte cellular compartments.
SPECIFIC AIMS are to test the hypotheses that ductal bile formation: (i) depends on expression and cellular compartmentalization of multiple cholangiocyte AQPs; (ii) is regulated by hormone-responsive, exocytic/endocytic recycling of AQP1 to the apical cholangiocyte membrane via specific cellular tracks (actin and tubulin cytoskeleton) and molecular motors (kinesin, dynein, and dynamin); and (iii) is driven by influx (absorptive) and efflux (secretory) osmotic gradients established by solute transporters/exchangers (bile acids/glucose/ions) heterogeneously expressed in cholangiocytes. We will test these hypotheses with an array of new methods including AQP knockout mice; cultured rat cholangiocytes transfected with AQP-green fluorescent fusion constructs; immunoisolation of AQP1-containing transport vesicles; apical and basolateral cholangiocyte membrane vesicles; intact closed or perfused rat bile duct units; subpopulations of rat cholangiocytes isolated from different bile duct segments; and computer generated 3-D reconstruction of the rat biliary tree. Results of these experiments will clarify which AQPs are expressed in cholangiocytes, their intracellular topography and segmental ductal distribution, what molecules control their cellular compartmentalization, and their physiologic relevance to ductal bile formation. Innovative aspects of the program include novel methodologies and concepts regarding ductal bile formation and cholangiocyte heterogeneity. The information generated will provide a theoretical framework for development of novel therapeutic strategies for the cholangiopathies, a group of cholestatic genetic/acquired hepatobiliary diseases in which the cholangiocyte is the principal target of diverse destructive processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK024031-25
Application #
6634860
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Serrano, Jose
Project Start
1978-12-01
Project End
2004-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
25
Fiscal Year
2003
Total Cost
$432,203
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Masyuk, Anatoliy I; Masyuk, Tatyana V; Lorenzo Pisarello, Maria J et al. (2018) Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target. Hepatology 67:1088-1108
Banales, Jesus M; Marzioni, Marco; LaRusso, Nicholas F et al. (2018) Cholangiocytes in health and disease: From basic science to novel treatments. Biochim Biophys Acta Mol Basis Dis 1864:1217-1219
Mansini, Adrian P; Lorenzo Pisarello, Maria J; Thelen, Kristen M et al. (2018) MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma. Hepatology 68:561-573
Lorenzo Pisarello, Maria; Masyuk, Tatyana V; Gradilone, Sergio A et al. (2018) Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease. Am J Pathol 188:981-994
Cheung, Angela C; Lorenzo Pisarello, Maria J; LaRusso, Nicholas F (2018) Pathobiology of biliary epithelia. Biochim Biophys Acta Mol Basis Dis 1864:1220-1231
Masyuk, Tatyana V; Masyuk, Anatoliy I; LaRusso, Nicholas F (2018) Polycystic liver disease: The interplay of genes causative for hepatic and renal cystogenesis. Hepatology 67:2462-2464
Loarca, Lorena; De Assuncao, Thiago M; Jalan-Sakrikar, Nidhi et al. (2017) Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis. Lab Invest 97:1385-1396
Masyuk, Tatyana V; Masyuk, Anatoliy I; LaRusso, Nicholas F (2017) Therapeutic Targets in Polycystic Liver Disease. Curr Drug Targets 18:950-957
Masyuk, Tatyana V; Masyuk, Anatoliy I; Lorenzo Pisarello, Maria et al. (2017) TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/G?s signaling. Hepatology 66:1197-1218
Holditch, Sara J; Schreiber, Claire A; Harris, Peter C et al. (2017) B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease. Kidney Int 92:657-668

Showing the most recent 10 out of 165 publications